Stocks - New Portfolio

Alex Marin

Stocks
Individual Investor
Ranked #20,793 out of 757,492 TipRanks' Investors
Success Rate
81%
428 out of 531
profitable transactions
Average Return
15.64%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 118.62%
6-Month Return▲ 58.49%
12-Month Return▲ 58.83%
YTD Return▲ 60.82%
Total Return▼ 24.07%

Best Trade

Opened at
Closed at
Gain▲ 244.61%

Bio

Investments

Performance

110.94%0-110.94%
▲ 14.08%
▲ 5.22%
▲ 3.99%
Feb 2024
▲ 5.05%
▲ 3.27%
▼ 1.77%
Mar 2024
▼ 12.40%
▼ 4.03%
▼ 11.50%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 11.70%
May 2024
▼ 2.25%
▲ 3.53%
▼ 18.56%
Jun 2024
▲ 25.76%
▲ 1.21%
▲ 5.42%
Jul 2024
▼ 4.21%
▲ 2.34%
▼ 11.60%
Aug 2024
▲ 5.59%
▲ 1.30%
▲ 110.94%
Sep 2024
TipRanks AverageS&P 500Investor Portfolio
▲ 14.08%▲ 5.22%▲ 3.99%
▲ 5.05%▲ 3.27%▼ 1.77%
▼ 12.40%▼ 4.03%▼ 11.50%
▲ 11.46%▲ 5.06%▲ 11.70%
▼ 2.25%▲ 3.53%▼ 18.56%
▲ 25.76%▲ 1.21%▲ 5.42%
▼ 4.21%▲ 2.34%▼ 11.60%
▲ 5.59%▲ 1.30%▲ 110.94%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Liminal BioSciences
▼ 81.48%
2
Close
Sep 25, 2023
Clovis Oncology
▼ 99.78%
4
Close
Jul 11, 2023
GeNeuro SA
▲ 37.88%
2
Close
Feb 17, 2023
Tyme Technologies
▼ 81.98%
2
Close
Sep 16, 2022
Syros Pharmaceuticals
0%
▼ 73.06%
1
Open
Sep 16, 2022
Achieve Life Sciences
0%
▼ 50.05%
1
Open
Jan 11, 2021
Nabriva Therapeutics
0%
▼ 99.82%
1
Open
Jan 11, 2021
Synlogic
0%
▼ 95.96%
1
Open
Jan 11, 2021
Purple Biotech
0%
▲ 72.77%
1
Open
Jan 11, 2021
Pulmatrix
0%
▼ 91.34%
1
Open
Jan 11, 2021
ObsEva
0%
▼ 99.50%
1
Open
Jan 11, 2021
ENDRA Life Sciences
0%
▼ 99.98%
1
Open
Jan 11, 2021
Checkpoint Therapeutics
0%
▼ 91.03%
1
Open
Jan 11, 2021
Galectin Therapeutics
0%
▲ 28.51%
1
Open
Jan 11, 2021
Atossa Therapeutics
0%
▲ 32.73%
1
Open
Jan 11, 2021
Daré Bioscience
0%
▼ 85.14%
1
Open
Jan 11, 2021
Baudax Bio
0%
▼ 100.00%
1
Open
Jan 11, 2021
Galmed Pharmaceuticals
0.06%
▼ 84.05%
1
Open
Dec 09, 2020
Callon
▲ 62.72%
5
Close
Dec 09, 2020
Cenovus Energy
▲ 26.71%
5
Close
Dec 09, 2020